{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T06:06:01Z","timestamp":1788242761713,"version":"build-2803163510"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurosci"],"published-print":{"date-parts":[[2011,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A reductase, known as statins, are commonly used as cholesterol-lowering drugs. During the past decade, evidence has emerged that statins also have neuroprotective effects. Research in the retina has shown that simvastatin, a commonly used statin, increases Akt phosphorylation <jats:italic>in vivo<\/jats:italic>, indicating that the PI3K\/Akt pathway contributes to the protective effects achieved. While research about neuroprotective effects have been conducted in several systems, the effects of statins on the inner ear are largely unknown.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>We evaluated whether the 3-hydroxy-3-methylglutaryl-coenzyme A reductase is present within the rat cochlea and whether simvastatin is able to protect auditory hair cells from gentamicin-induced apoptotic cell death in a <jats:italic>in vitro<\/jats:italic> mouse model. Furthermore, we evaluated whether simvastatin increases Akt phosphorylation in the organ of Corti. We detected 3-hydroxy-3-methylglutaryl-coenzyme A reductase mRNA in organ of Corti, spiral ganglion, and stria vascularis by reverse transcriptase-polymerase chain reaction (RT-PCR). Moreover, we observed a dose-dependent and significant reduction of hair cell loss in organs of Corti treated with simvastatin in addition to gentamicin, as compared to samples treated with gentamicin alone. The protective effect of simvastatin was reversed by addition of mevalonate, a downstream metabolite blocked by simvastatin, demonstrating the specificity of protection. Finally, Western blotting showed an increase in organ of Corti Akt phosphorylation after simvastatin treatment <jats:italic>in vitro<\/jats:italic>.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>These results suggest a neuroprotective effect of statins in the inner ear, mediated by reduced 3-hydroxy-3-methylglutaryl-coenzyme A reductase metabolism and Akt activation.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2202-12-114","type":"journal-article","created":{"date-parts":[[2011,11,16]],"date-time":"2011-11-16T03:27:04Z","timestamp":1321414024000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Simvastatin protects auditory hair cells from gentamicin-induced toxicity and activates Akt signaling in vitro"],"prefix":"10.1186","volume":"12","author":[{"given":"Yves","family":"Brand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristian","family":"Setz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soledad","family":"Levano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alwin","family":"Listyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Chavez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwang","family":"Pak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Sung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vesna","family":"Radojevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allen F","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Bodmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,11,14]]},"reference":[{"key":"2462_CR1","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1097\/01.moo.0000136873.56878.56","volume":"12","author":"JI Matsui","year":"2004","unstructured":"Matsui JI, Cotanche DA: Sensory hair cell death and regeneration: two halves of the same equation. Curr Opin. Otolaryngol. Head Neck Surg. 2004, 12: 418-425. 10.1097\/01.moo.0000136873.56878.56.","journal-title":"Curr Opin. Otolaryngol. Head Neck Surg"},{"key":"2462_CR2","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1097\/01.moo.0000186799.45377.63","volume":"13","author":"AG Cheng","year":"2005","unstructured":"Cheng AG, Cunningham LL, Rubel EW: Mechanisms of hair cell death and protection. Curr Opin Otolaryngol Head Neck Surg. 2005, 13: 343-348. 10.1097\/01.moo.0000186799.45377.63.","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"key":"2462_CR3","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1055\/s-2004-814280","volume":"83","author":"J Lautermann","year":"2004","unstructured":"Lautermann J, Dehne N, Jahnke K: Aminoglycoside- and cisplatin-ototoxicity: from basic science to clinics. Laryngorhinootologie. 2004, 83: 317-323.","journal-title":"Laryngorhinootologie"},{"key":"2462_CR4","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1016\/S1359-6446(05)03552-X","volume":"10","author":"LP Rybak","year":"2005","unstructured":"Rybak LP, Whitworth CA: Ototoxicity: therapeutic opportunities. Drug Discov Today. 2005, 10: 1313-1321. 10.1016\/S1359-6446(05)03552-X.","journal-title":"Drug Discov Today"},{"key":"2462_CR5","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/j.neuroscience.2003.08.041","volume":"122","author":"A Battaglia","year":"2003","unstructured":"Battaglia A, Pak K, Brors D, Bodmer D, Frangos J, Ryan A: Involvement of ras activation in toxic hair cell damage of the mammalian cochlea. Neuroscience. 2003, 122: 1025-1035. 10.1016\/j.neuroscience.2003.08.041.","journal-title":"Neuroscience"},{"key":"2462_CR6","doi-asserted-by":"publisher","first-page":":81","DOI":"10.1016\/S0378-5955(02)00514-2","volume":"172","author":"D Bodmer","year":"2002","unstructured":"Bodmer D, Brors D, Pak K, Gloddek B, Ryan AF: Rescue of auditory hair cells from aminoglycoside toxicity by Clostridium difficile toxin B, an inhibitor of the small GTPases Rho\/Rac\/Cdc42. Hear Res. 2002, 172: :81-86. 10.1016\/S0378-5955(02)00514-2.","journal-title":"Hear Res"},{"key":"2462_CR7","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1523\/JNEUROSCI.20-01-00043.2000","volume":"20","author":"U Pirvola","year":"2000","unstructured":"Pirvola U, Xing-Qun L, Virkkala J, Saarma M, Murakata C, Camoratto AM, Walton KM, Ylikoski J: Rescue of hearing, auditory hair cells, and neurons by CEP-1347\/KT7515, an inhibitor of c-Jun N-terminal kinase activation. J Neurosci. 2000, 20: 43-50.","journal-title":"J Neurosci"},{"key":"2462_CR8","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1055\/s-2002-36100","volume":"81","author":"D Bodmer","year":"2002","unstructured":"Bodmer D, Brors D, Bodmer M, Ryan AF: Rescue of auditory hair cells from ototoxicity by CEP-11004, an inhibitor of the JNK signalling pathway. Laryngorhinootologie. 2002, 81: 853-856. 10.1055\/s-2002-36100.","journal-title":"Laryngorhinootologie"},{"key":"2462_CR9","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1007\/s10162-006-0050-y","volume":"7","author":"WH Chung","year":"2006","unstructured":"Chung WH, Pak K, Lin B, Webster N, Ryan AF: A PI3K pathway mediates hair cell survival an opposes gentamicin toxiciy in neonatal rat organ of Corti. J Assoc Res Otolaryngol. 2006, 7: 372-382.","journal-title":"J Assoc Res Otolaryngol"},{"key":"2462_CR10","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/S0736-5748(99)00094-5","volume":"18","author":"T Huang","year":"2000","unstructured":"Huang T, Chen AG, Stupak H, Liu W, Kim A, Staecker H, Lefebvre PP, Malgrange B, Kopke R, Moonen G, Van De Water TR: Oxidative stress-induced apoptosis of cochlear sensory cells: otoprotective strategies. Int J Dev Neurosci. 2000, 18: 259-270. 10.1016\/S0736-5748(99)00094-5.","journal-title":"Int J Dev Neurosci"},{"key":"2462_CR11","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.anl.2004.11.006","volume":"32","author":"T Okuda","year":"2005","unstructured":"Okuda T, Sugahara K, Takemoto T, Shimogori H, Yamashita H: Inhibition of caspases alleviates gentamicin-induced cochlear damage in guinea pigs. Auris Nasus Larynx. 2005, 32: 33-37. 10.1016\/j.anl.2004.11.006.","journal-title":"Auris Nasus Larynx"},{"key":"2462_CR12","first-page":"8-14","volume":"19","author":"GL Castilla","year":"2008","unstructured":"Castilla GL, Del Carmen Fernandez MM, Lopez Chozas JM, Jimene H: Statins in stroke prevention: what an internist should know. Eur J Intern Med. 2008, 19: 8-14.","journal-title":"Eur J Intern Med"},{"key":"2462_CR13","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1161\/STROKEAHA.107.501361","volume":"39","author":"A Nassief","year":"2008","unstructured":"Nassief A, Marsh JD: Statin therapy for stroke prevention. Stroke. 2008, 39: 1042-1048. 10.1161\/STROKEAHA.107.501361.","journal-title":"Stroke"},{"key":"2462_CR14","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1084\/jem.20021425","volume":"197","author":"O Aktas","year":"2003","unstructured":"Aktas O, Waiczies S, Smorodchenko A, Dorr J, Seeger B, Prozorovski T, Sallach S, Endres M, Brocke S, Nitsch R, Zipp F: A treatment of relapsing paralysis in experimental encephalomyelitis by targeting Th1 cells through atorvastatin. J Exp Med. 2003, 197: 725-733. 10.1084\/jem.20021425.","journal-title":"J Exp Med"},{"key":"2462_CR15","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1093\/brain\/awh068","volume":"127","author":"S Floris","year":"2004","unstructured":"Floris S, Blezer EL, Schreibelt G, D\u00f6pp E, van der Pol SM, Schadee-Eestermans IL, Nicolay K, Dijkstra CC, de Vries HE: Blood-brain barrier permeability and monocyte infiltration in experimental allergic encephalomyelitis: a quantitative MRI study. Brain. 2004, 127: 616-627.","journal-title":"Brain"},{"key":"2462_CR16","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1096\/fj.02-1014fje","volume":"17","author":"J Greenwood","year":"2003","unstructured":"Greenwood J, Walters CE, Pryce G, Kanuga N, Beraud E, Baker D, Adamson P: Lovastatin inhibits brain endothelial cell Rho-mediated lymphocyte migration and attenuates experimental autoimmune encephalomyelitis. FASEB J. 2003, 17: 905-907.","journal-title":"FASEB J"},{"key":"2462_CR17","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1002\/jnr.20130","volume":"77","author":"AS Paintlia","year":"2004","unstructured":"Paintlia AS, Paintlia MK, Singh AK, Stanislaus R, Gilg AG, Barbosa E, Singh I: Regulation of gene expression associated with acute experimental autoimmune encephalomyelitis by Lovastatin. J Neurosci Res. 2004, 77: 63-81. 10.1002\/jnr.20130.","journal-title":"J Neurosci Res"},{"key":"2462_CR18","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.brainresrev.2007.10.010","volume":"58","author":"C Berger","year":"2008","unstructured":"Berger C, Xia F, Maurer MH, Schwab S: Neuroprotection by pravastatin in acute ischemic stroke in rats. Brain Res Rev. 2008, 58: 48-56. 10.1016\/j.brainresrev.2007.10.010.","journal-title":"Brain Res Rev"},{"key":"2462_CR19","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/sj.jcbfm.9600034","volume":"25","author":"J Chen","year":"2005","unstructured":"Chen J, Zhang C, Jiang H, Zhang L, Robin A, Katakowski M, Lu M, Chopp M: Atorvastatin induction of VEGF and BDNF promotes brain plasticity after stroke in mice. J Cereb Blood Flow Metab. 2005, 25: 281-290. 10.1038\/sj.jcbfm.9600034.","journal-title":"J Cereb Blood Flow Metab"},{"key":"2462_CR20","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1161\/01.ATV.0000044458.23905.3B","volume":"23","author":"L Sironi","year":"2003","unstructured":"Sironi L, Cimino M, Guerrini U, Calvio AM, Lodetti B, Asdente M, Balduini W, Paoletti R, Tremoli E: Treatment with statins after induction of focal ischemia in rats reduces the extent of brain damage. Arterioscler Thromb Vasc Biol. 2003, 23: 322-327. 10.1161\/01.ATV.0000044458.23905.3B.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2462_CR21","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1172\/JCI200113152","volume":"108","author":"S Dimmeler","year":"2001","unstructured":"Dimmeler S, Aicher A, Vasa M, Mildner-Rihm C, Adler K, Tiemann M, R\u00fctten H, Fichtlscherer S, Martin H, Zeiher AM: HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase\/Akt pathway. J Clin Invest. 2001, 108: 391-497.","journal-title":"J Clin Invest"},{"key":"2462_CR22","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1038\/79510","volume":"6","author":"Y Kureishi","year":"2000","unstructured":"Kureishi Y, Luo Z, Shiojima I, Bialik A, Fulton D, Lefer DJ, Sessa WC, Walsh E: The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals. Nat Med. 2000, 6: 1004-1010. 10.1038\/79510.","journal-title":"Nat Med"},{"key":"2462_CR23","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.nbd.2005.08.003","volume":"21","author":"A Kretz","year":"2006","unstructured":"Kretz A, Schmeer C, Tausch S, Isenmann S: Simvastatin promotes heat shock protein 27 expression and Akt activation in the rat retina an protects axotomized retinal ganglion cells in vivo. Neurobiol Dis. 2006, 21: 421-430. 10.1016\/j.nbd.2005.08.003.","journal-title":"Neurobiol Dis"},{"key":"2462_CR24","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1159\/000236014","volume":"71","author":"Q Cai","year":"2009","unstructured":"Cai Q, Du X, Zhou B, Cai C, Kermany MH, Zhang C, Yoo T: Effects of simvastatin on plasma lipoproteins and hearing loss in apolipoprotein E gene-deficient mice. ORL J Otorhinolaryngol Relat Spec. 2009, 71: 244-250. 10.1159\/000236014.","journal-title":"ORL J Otorhinolaryngol Relat Spec"},{"key":"2462_CR25","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.neulet.2006.10.032","volume":"411","author":"J Syka","year":"2007","unstructured":"Syka J, Ouda L, Nachtigal P, Solichova D, Semecky V: Atrovastin slows down the deterioration of inner ear function with age in mice. Neurosci Lett. 2007, 411: 112-116. 10.1016\/j.neulet.2006.10.032.","journal-title":"Neurosci Lett"},{"key":"2462_CR26","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1054\/mehy.2001.1535","volume":"58","author":"C Borghi","year":"2002","unstructured":"Borghi C, Modugno G, Pirodda A: Possible role of HMG-CoA reductase inhibiors for the treament of sudden sensorineural hearing loss (SSHL). Med Hypotheses. 2002, 58: 399-402. 10.1054\/mehy.2001.1535.","journal-title":"Med Hypotheses"},{"key":"2462_CR27","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1097\/01.mao.0000271673.33683.7b","volume":"28","author":"B Olzowy","year":"2007","unstructured":"Olzowy B, Canis M, John-Martin Hempel, Brigit Mazurek, Suckf\u00fcll M: Effect of atrovastin on progression of sensorineural hearing loss and tinnitus in the elderly: results of a prospective, randomized, double-blind clinical trial. Otol Neurootol. 2007, 28: 455-458. 10.1097\/01.mao.0000271673.33683.7b.","journal-title":"Otol Neurootol"},{"key":"2462_CR28","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1007\/s10162-008-0118-y","volume":"9","author":"LL Chiu","year":"2008","unstructured":"Chiu LL, Cunningham LL, Raible DW, Rubel EW, Ou HC: Using the zebrafish lateral line to screen for ototoxicity. J Assoc Res Otolaryngol. 2008, 9: 178-190. 10.1007\/s10162-008-0118-y.","journal-title":"J Assoc Res Otolaryngol"},{"key":"2462_CR29","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1080\/00016480802163358","volume":"129","author":"DS Park","year":"2009","unstructured":"Park DS, So HS, Lee JH, Park H, Lee YJ, Cho JH, Yoon KH, Park C, Yun K, Park R: Simvastatin treatment induces morphology alterations and apoptosis in murine cochlear neuronal cells. Acta Otolaryngol. 2009, 129: 166-74. 10.1080\/00016480802163358.","journal-title":"Acta Otolaryngol"},{"key":"2462_CR30","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1146\/annurev.pharmtox.45.120403.095748","volume":"45","author":"JK Liao","year":"2005","unstructured":"Liao JK, Lauf U: Pleiotropic effects of statins. Annu Rev Pharmacol Toxicol. 2005, 45: 89-118. 10.1146\/annurev.pharmtox.45.120403.095748.","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"2462_CR31","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S0163-7258(03)00055-X","volume":"99","author":"AS Wierzbicki","year":"2003","unstructured":"Wierzbicki AS, Poston R, Ferro A: The lipid and non-lipid effects of statins. Pharmacol Ther. 2003, 99: 95-112. 10.1016\/S0163-7258(03)00055-X.","journal-title":"Pharmacol Ther"},{"key":"2462_CR32","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.clinbiochem.2007.03.016","volume":"40","author":"I Buhaescu","year":"2007","unstructured":"Buhaescu I, Izzedine H: Mevalonate pathway: a review of clinical and therapeutical implications. Clin Biochem. 2007, 40: 575-584. 10.1016\/j.clinbiochem.2007.03.016.","journal-title":"Clin Biochem"},{"key":"2462_CR33","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/S0008-6363(01)00540-5","volume":"53","author":"U Laufs","year":"2002","unstructured":"Laufs U, Kilter H, Konkol C, Wassmann S, B\u00f6hm M, Nickening G: Impact of HMG CoA reductase inhibitor on small GTPases in the heart. Cardiovasc Res. 2002, 53: 911-920. 10.1016\/S0008-6363(01)00540-5.","journal-title":"Cardiovasc Res"},{"key":"2462_CR34","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S0098-2997(97)00014-9","volume":"18","author":"SA Mortensen","year":"1997","unstructured":"Mortensen SA, Leth A, Agner E, Rohde M: Dose-related decrease of serum coenzyme Q10 during treatment with HMG-CoA reductase inhibitors. Mol Aspects Med. 1997, 18: 137-144.","journal-title":"Mol Aspects Med"},{"key":"2462_CR35","doi-asserted-by":"publisher","first-page":"373","DOI":"10.2165\/0129784-200808060-00004","volume":"8","author":"BA Golomb","year":"2008","unstructured":"Golomb BA, Evans MA: Statins adverse effects: a review of the literature and evidence for a mitochondrial mechanism. Am J Cardiovasc Drugs. 2008, 8: 373-418. 10.2165\/0129784-200808060-00004.","journal-title":"Am J Cardiovasc Drugs"},{"key":"2462_CR36","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.brainres.2008.12.027","volume":"1257","author":"AR Fetoni","year":"2009","unstructured":"Fetoni AR, Piacentini R, Fiorita A, Paludetti G, Troiani D: Water-soluble Coenzyme Q10 formulation (Q-ter) promotes outer hair cell survival in guinea pig model of noise induced hearing loss (NIHL). Brain Res. 2009, 1257: 108-116.","journal-title":"Brain Res"},{"key":"2462_CR37","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1097\/MAO.0b013e31818256a9","volume":"29","author":"EM Keithley","year":"2008","unstructured":"Keithley EM, Wang X, Barkdull GC: Tumor necrosis factor alpha can induce recruitment of inflammatory cells to the cochlea. Otol Neurootol. 2008, 29: 854-859. 10.1097\/MAO.0b013e31818256a9.","journal-title":"Otol Neurootol"},{"key":"2462_CR38","first-page":"3","volume":"502","author":"HM Sobkowicz","year":"1993","unstructured":"Sobkowicz HM, Loftus JM, Slapnick SM: Tissue culture of the organ of Corti. Acta Otolaryngol Suppl. 1993, 502: 3-36.","journal-title":"Acta Otolaryngol Suppl"},{"key":"2462_CR39","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1038\/sj.bjp.0703920","volume":"132","author":"K Bogman","year":"2001","unstructured":"Bogman K, Peyer AK, T\u00f6r\u00f6k M, Kusters E, Drewe J: HMG-CoA reductase inhibitors and P-glycoprotein modulation. Br J Pharmacol. 2001, 132: 1183-1192. 10.1038\/sj.bjp.0703920.","journal-title":"Br J Pharmacol"}],"container-title":["BMC Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2202-12-114.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T17:52:32Z","timestamp":1630518752000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurosci.biomedcentral.com\/articles\/10.1186\/1471-2202-12-114"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11,14]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["2462"],"URL":"https:\/\/doi.org\/10.1186\/1471-2202-12-114","relation":{},"ISSN":["1471-2202"],"issn-type":[{"value":"1471-2202","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,11,14]]},"assertion":[{"value":"19 August 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2011","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2011","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"114"}}